Items tagged with HIV coinfection
In women with HIV, TB preventive therapy poses greater risk in pregnancy than postpartum (post)
October 2, 2019: Study results published today help clarify how to safely prevent tuberculosis (TB) in women living with HIV who are pregnant or have recently given birth, are taking antiretroviral therapy, and live where TB is highly prevalent.
Treatment-decision score for children with HIV and suspected TB (post)
A new treatment-decision score for the diagnosis of tuberculosis (TB) in children with HIV performed well, and when used in an algorithm may facilitate prompt treatment decision making for children at a high risk for mortality, according to data published in Pediatrics.
Dolutegravir-based regimen safe and effective for people taking rifampicin for TB (post)
A study from Botswana published in the October issue of the Journal of Acquired Immune Deficiency Syndromes provides important scientific evidence, but not strong enough data for a policy change, on the use of a dolutegravir-based antiretroviral therapy (ART) regimen along with a rifampicin-based anti-tuberculosis (TB) regimen, for people living with HIV and TB coinfection.
Updated Cochrane Review published: Lateral flow urine lipoarabinomannan assay for detecting active TB in people living with HIV (post)
Tuberculosis (TB) causes more deaths in people living with HIV than any other disease, with more than 300,000 deaths in 2017. When detected, early TB can be treated effectively; however, people with advanced HIV are at high risk of death, often without knowing they have TB. Diagnosis of TB in HIV-positive people is often complicated because they may not present with typical symptoms, and sputum-based test are not always effective because many have disease outside the lungs and may not be able to produce sputum.
HIV, pregnancy and TB medication: Do they mix? (post)
Tuberculosis disease is a global killer, infecting 10 million people every year and taking the lives of 1.5 million. Being HIV positive is a risk factor for contracting tuberculosis disease and dying from it. Pregnancy also leaves women vulnerable to the ravages of tuberculosis, and pregnant women who also have HIV are especially at risk.
50th Union World Conference on Lung Health: Prevention trial targets multidrug-resistant TB (post)
HYDERABAD, INDIA – The National Institute of Allergy and Infectious Diseases is investing $70 million in a phase III clinical trial assessing the use of tuberculosis treatments in preventing multidrug-resistant tuberculosis infection among high-risk individuals, including infected household contacts of MDR-TB patients and people living with HIV, institute officials announced here.
Tereza Kasaeva: World AIDS Day message (post)
Dr Tereza Kasaeva, Director of the World Health Organization Global TB Program, released a message on the occasion of World AIDS Day, 1 December 2019.
To meet HIV world health goals, TB must also be reduced (post)
New York, Dec. 1, 2019 — The World Health Organization has set a goal of ending the AIDS epidemic by 2030. To achieve that goal, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organizations on World AIDS Day to strengthen their response to AIDS and tuberculosis.
Lack of clinical response to antibiotics ‘strong predictor’ of TB among adults with HIV (post)
Failure to respond to antibiotics may serve as a strong indicator of tuberculosis among people living with HIV who have symptoms of the disease, according to findings published in Open Forum Infectious Diseases.
Xpert Ultra improves TB meningitis detection, does not rule out disease (post)
In an HIV-positive population, the Xpert MTB/RIF Ultra assay detected tuberculous meningitis with higher sensitivity than the older Xpert assay and a mycobacterial growth indicator tube culture, according to findings published in The Lancet.
Page 33 of 52 · Total posts: 0
←First 32 33 34 Last→